Free Trial

Celcuity (CELC) Competitors

Celcuity logo
$12.49 -0.43 (-3.33%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$12.30 -0.19 (-1.52%)
As of 06/11/2025 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CELC vs. ARDT, PGNY, NHC, PACS, GRAL, TDOC, VRDN, AHCO, CDNA, and AVAH

Should you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Ardent Health Partners (ARDT), Progyny (PGNY), National HealthCare (NHC), PACS Group (PACS), Grail (GRAL), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Celcuity vs. Its Competitors

Celcuity (NASDAQ:CELC) and Ardent Health Partners (NYSE:ARDT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking, institutional ownership and profitability.

Ardent Health Partners has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Ardent Health Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$63.78M-$3.03-4.12
Ardent Health Partners$6.02B0.32$53.90M$1.638.17

Celcuity presently has a consensus price target of $30.80, indicating a potential upside of 146.60%. Ardent Health Partners has a consensus price target of $20.67, indicating a potential upside of 55.17%. Given Celcuity's stronger consensus rating and higher probable upside, research analysts clearly believe Celcuity is more favorable than Ardent Health Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
Ardent Health Partners
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
3.00

Ardent Health Partners' return on equity of 0.00% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -62.66% -39.78%
Ardent Health Partners N/A N/A N/A

63.3% of Celcuity shares are held by institutional investors. 15.8% of Celcuity shares are held by company insiders. Comparatively, 1.7% of Ardent Health Partners shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Celcuity and Celcuity both had 4 articles in the media. Celcuity's average media sentiment score of 1.74 beat Ardent Health Partners' score of 1.23 indicating that Celcuity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Ardent Health Partners
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Celcuity received 317 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 89.66% of users gave Ardent Health Partners an outperform vote while only 67.92% of users gave Celcuity an outperform vote.

CompanyUnderperformOutperform
CelcuityOutperform Votes
343
67.92%
Underperform Votes
162
32.08%
Ardent Health PartnersOutperform Votes
26
89.66%
Underperform Votes
3
10.34%

Summary

Ardent Health Partners beats Celcuity on 9 of the 15 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELC vs. The Competition

MetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$472.95M$3.11B$5.57B$8.62B
Dividend YieldN/A31.25%5.28%4.18%
P/E Ratio-4.7913.9627.1720.06
Price / SalesN/A179.33409.72157.10
Price / CashN/A57.5638.2534.64
Price / Book2.284.817.064.70
Net Income-$63.78M-$22.21M$3.23B$247.88M
7 Day Performance6.03%3.94%2.89%2.66%
1 Month Performance16.95%5.62%9.06%6.40%
1 Year Performance-16.73%15.89%31.40%14.07%

Celcuity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELC
Celcuity
1.9414 of 5 stars
$12.49
-3.3%
$30.80
+146.6%
-14.8%$472.95MN/A-4.7940Positive News
ARDT
Ardent Health Partners
3.3043 of 5 stars
$13.63
-8.3%
$20.67
+51.6%
N/A$1.95B$6.02B8.3624,200Positive News
PGNY
Progyny
0.8691 of 5 stars
$21.97
+1.3%
$23.45
+6.8%
-22.8%$1.88B$1.21B37.88310
NHC
National HealthCare
N/A$104.46
-1.5%
N/A+1.2%$1.62B$1.37B13.0912,400Positive News
PACS
PACS Group
3.4185 of 5 stars
$10.41
-0.3%
$34.29
+229.5%
-64.1%$1.59B$3.56B0.0032,433
GRAL
Grail
0.5168 of 5 stars
$40.03
+4.4%
$31.50
-21.3%
N/A$1.44B$130.71M-0.661,360High Trading Volume
TDOC
Teladoc Health
3.228 of 5 stars
$7.40
+1.8%
$9.60
+29.7%
-29.0%$1.30B$2.55B-1.285,100
VRDN
Viridian Therapeutics
1.8125 of 5 stars
$14.86
+1.2%
$36.70
+147.0%
+19.5%$1.21B$302K-3.4550Positive News
AHCO
AdaptHealth
3.0776 of 5 stars
$8.82
-0.9%
$13.40
+51.9%
-21.6%$1.19B$3.25B-5.3510,900Positive News
CDNA
CareDx
3.8059 of 5 stars
$19.72
+1.0%
$30.33
+53.8%
+34.9%$1.10B$346.42M-7.30740Positive News
AVAH
Aveanna Healthcare
0.9147 of 5 stars
$5.47
-0.7%
$5.13
-6.3%
+109.2%$1.07B$2.09B-16.0933,000Positive News

Related Companies and Tools


This page (NASDAQ:CELC) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners